Could a once-abandoned obesity drug be revived in osteoporosis? by Angus Liu Thursday, December 13, 2018 The Harvard researcher who first discovered the "exercise hormone" irisin reports it may be useful in bone formation.
Improving arthritis treatment with a cartilage-penetrating nanocarrier by Angus Liu Wednesday, November 28, 2018 MIT scientists designed a material that allows osteoarthritis drugs to more deeply penetrate cartilage-generating tissues.
Stanford study identifies human skeletal stem cell by Angus Liu Thursday, September 20, 2018 A newly found stem cell can differentiate into just bone cells without the unwanted lineages found in previous cultures.
Promoting blood vessel growth could treat osteoporosis by Arlene Weintraub Friday, May 25, 2018 Researchers have discovered a molecule that promotes the growth of blood vessels in bone, reversing weakening and helping fractures heal.
NuVasive’s limb-lengthening tech earns expanded FDA clearance by Amirah Al Idrus Friday, October 13, 2017 The FDA has expanded the clearance of NuVasive’s limb-lengthening system to include bone transport.
Shock for Amgen, UCB as side effects undermine romo trial by Phil Taylor Monday, May 22, 2017 Amgen and UCB's romosozumab trounced a comparator drug in a trial in osteoporosis, but there's a big catch: The therapy seems to cause side effects that will delay and could scupper its chances of reaching the market.
Gene therapy and stem cells prompt bone to regrow itself by Amirah Al Idrus Wednesday, May 17, 2017 A Cedars-Sinai-led team has developed a treatment for fractured bone using ultrasound, stem cells and gene therapy.
J&J buys 3D-printing tech to create bone-healing implants by Nick Paul Taylor Thursday, April 20, 2017 Johnson & Johnson has acquired 3D-printing technology from Tissue Regeneration Systems.
Ultragenyx on course for XLH drug filing after phase 3 win by Phil Taylor Wednesday, April 19, 2017 Ultragenyx needed a win for its lead drug burosumab after a midstage pipeline failure and delivered with a good set of phase 3 results.